We are live on
!
Find out more
AP
AtonRa Partners Portfolio holdings
AUM
$50.2M
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+14.92%
1 Year Est. Return
+47.76%
3 Year Est. Return
+48.32%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$78.5M
AUM Growth
-$23.3M
(-23%)
Cap. Flow
-$22.9M
Cap. Flow
% of AUM
-29.17%
Top 10 Holdings %
Top 10 Hldgs %
20.72%
Holding
116
New
2
Increased
2
Reduced
109
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
+$476K |
| 2 |
Coherent
COHR
|
+$315K |
| 3 |
Outset Medical
OM
|
+$41.2K |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$30.2K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$1.38M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$1.18M |
| 3 |
First Solar
FSLR
|
+$934K |
| 4 |
SolarEdge
SEDG
|
+$906K |
| 5 |
Wolfspeed
WOLF
|
+$803K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.97% |
| 2 | Healthcare | 38.08% |
| 3 | Financials | 6.07% |
| 4 | Industrials | 5.49% |
| 5 | Communication Services | 1.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Okta
OKTA
$24.1B
| $301K | 0.38% |
4,408
-466
| -10% | -$26.6K |
|
102
Arvinas
ARVN
$518M
| $280K | 0.36% |
8,197
-2,217
| -21% | -$93.3K |
|
103
Coinbase
COIN
$41.7B
| $279K | 0.36% |
7,897
-121
| -2% | -$6.38K |
|
|
ICPT
104
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $269K | 0.34% |
21,764
-5,886
| -21% | -$83.3K |
|
105
Tesla
TSLA
$1.24T
| $267K | 0.34% |
2,167
-1,882
| -46% | -$356K |
|
106
Teladoc Health
TDOC
$1.58B
| $231K | 0.29% |
9,770
-1,955
| -17% | -$52.7K |
|
|
NVEI
107
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $225K | 0.29% |
8,860
-1,651
| -16% | -$46.8K |
|
|
NSTG
108
DELISTED
NanoString Technologies, Inc.
NSTG
| $196K | 0.25% |
24,561
-6,396
| -21% | -$55.5K |
|
109
Virgin Galactic
SPCE
$320M
| $188K | 0.24% |
2,707
-286
| -10% | -$26.7K |
|
110
Omnicell
OMCL
$1.86B
| $164K | 0.21% |
3,252
-986
| -23% | -$59.2K |
|
111
Fate Therapeutics
FATE
$281M
| $150K | 0.19% |
14,912
-4,034
| -21% | -$75.8K |
|
112
Nkarta
NKTX
$162M
| $134K | 0.17% |
22,424
-6,064
| -21% | -$61.2K |
|
113
Marathon Digital Holdings
MARA
$4.62B
| $124K | 0.16% |
36,248
-557
| -2% | -$4.68K |
|
114
Sunrun
RUN
$2.37B
| – | – |
-3,628
| Closed | -$100K |
|
|
RCM
115
DELISTED
R1 RCM Inc. Common Stock
RCM
| – | – |
-33,252
| Closed | -$616K |
|
|
ABMD
116
DELISTED
Abiomed Inc
ABMD
| – | – |
-4,803
| Closed | -$1.18M |
|
Similar funds
JCI
SC
AOGP
ACJ
UFG
KC
P
AMC
AtonRa Partners's Q4 2022 Portfolio in Review
As of Q4 2022, AtonRa Partners held 116 positions worth $78.5M, down 23% from $102M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
AtonRa Partners withdrew a net $22.9M in Q4 2022, closing 3 positions and reducing 109 holdings. Its most notable exit was Abiomed Inc, an estimated $1.18M position sold in full.
By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 49% a quarter earlier, followed by Healthcare and Financials.
Against the trend, AtonRa Partners opened a new position in Inari Medical, Inc. Common Stock worth $417K.
- AtonRa Partners's largest Q4 2022 buy was Inari Medical, Inc. Common Stock: 6,566 shares worth $417K.
- AtonRa Partners added most to Outset Medical in Q4 2022, an estimated $41.2K increase.
- AtonRa Partners's biggest Q4 2022 reduction was Enphase Energy, cutting an estimated $1.38M.
- AtonRa Partners fully exited Abiomed Inc in Q4 2022, selling an estimated $1.18M.
- AtonRa Partners's ten largest holdings make up 21% of its $78.5M portfolio in Q4 2022.
- AtonRa Partners opened 2 new positions and closed 3 in Q4 2022.
- AtonRa Partners's portfolio value fell 23% quarter-over-quarter to $78.5M.
Based on AtonRa Partners's 13F filing for Q4 2022, filed 2 Feb 2023.